IperionX (NASDAQ:IPX) Receives New Coverage from Analysts at ThinkEquity

ThinkEquity assumed coverage on shares of IperionX (NASDAQ:IPXGet Free Report) in a research note issued on Monday, Benzinga reports. The firm set a “buy” rating and a $20.00 price target on the stock. ThinkEquity’s target price would indicate a potential upside of 50.60% from the company’s current price.

IperionX Stock Performance

IPX stock traded up $0.01 during midday trading on Monday, hitting $13.28. 5,407 shares of the stock were exchanged, compared to its average volume of 33,707. IperionX has a fifty-two week low of $6.51 and a fifty-two week high of $16.50. The stock’s 50-day moving average price is $14.17 and its 200-day moving average price is $13.03.

Institutional Investors Weigh In On IperionX

A hedge fund recently raised its stake in IperionX stock. B. Riley Financial Inc. increased its position in IperionX Limited (NASDAQ:IPXFree Report) by 3.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 337,762 shares of the company’s stock after buying an additional 10,684 shares during the period. IperionX comprises 4.9% of B. Riley Financial Inc.’s portfolio, making the stock its 4th largest holding. B. Riley Financial Inc. owned approximately 1.48% of IperionX worth $5,036,000 at the end of the most recent quarter. 2.76% of the stock is owned by institutional investors and hedge funds.

About IperionX

(Get Free Report)

IperionX’s mission is to be the leading developer of low carbon, sustainable, critical material supply chains focused on advanced industries including space, aerospace, electric vehicles and 3D printing. IperionX’s breakthrough titanium technologies have demonstrated the potential to produce titanium products that are sustainable, 100% recyclable, have low carbon intensity and to do so at product qualities that meet or exceed current industry standards.

Featured Articles

Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.